UrbanKisaanWinter 2020Active☆Watch⊞Compare

UrbanKisaan is one of 233 Biotech companies tracked from Hyderabad, Telangana, India, on record since 2020. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst”

Foundation models and autonomous chambers for plant biology

UrbanKisaan is an AI-for-plant-biology company. We build foundation models and the physical infrastructure that trains them. Shipping a single new seed variety takes about ten+ years. Two on germplasm, three on crosses and selection, three or four on field trials, one on regulatory. Inside that decade, prediction and experiment never properly meet. DNA is abundant, phenotype data is scarce and unpaired, and the cycle never trains itself. We closed that loop. Three foundation models cover the upstream science. Aadi is a 48-layer transformer trained from scratch on the public and proprietary corpus of plant genomes; it reads plant DNA and ranks variants before any wet-lab spend. Jeeva is the genotype-to-phenotype model that turns a seed and a target environment into yield, flowering, maturity, and height with confidence intervals plus per-locus attribution. Akash is the geospatial backbone - it maps every pixel of every field to crop class and growing condition. Two pieces of physical infrastructure close the downstream half. GeneRush is a controlled-environment chamber engineered for speed: extended photoperiod, optimized temperature, integrated phenomics. Wheat reaches anthesis in 38 days. Breeding programs run 4–6 generations a year instead of 1–2. GrowRush takes that same chamber to commercial production scale, where every harvest is also a labelled phenotype training pair flowing back to Jeeva. The unit is paid for by what it grows; the science works because the unit is identical to the chamber the AI was trained on. Every cycle produces proprietary genotype-to-phenotype data the next generation of models needs. The ten-year breeding cycle compresses toward three. We are already commercial

As reported in public records reported — not modeled.

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

No staged rounds to sequence.

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Benchmarked against 233 companies in Biotech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Raised more than 67% of sector peers (real $). Modeled value above 67% of peers (estimate).

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

UrbanKisaan is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

See where UrbanKisaan sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

If you work at UrbanKisaan, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.